IPO Listed — 23 Mar 2026
Listing Price: ₹467.70
Innovision IPO GMP History | Listing Price ₹467.70 & Kostak Rate
Innovision IPO has been listed on March 23, 2026 at a listing price of ₹467.70, against the issue price of ₹548 — a loss of ₹80.3 (-14.65%). The GMP peaked at ₹66 on 11 March 2026 and reached a low of ₹-95 on 21 March 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Innovision IPO raised ₹255 Cr. through its IPO at a price band of ₹521 to ₹548 per share, with a lot size of 27 shares. The IPO was open for subscription from 10 Mar 2026 to 17 Mar 2026.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 21 Mar 2026 | ₹ -95 | -17% | ₹ 0 | ₹ 0 | |
| 20 Mar 2026 | ₹ -90 | -16% | ₹ 0 | ₹ 0 | |
| 19 Mar 2026 | ₹ -80 | -15% | ₹ 0 | ₹ 0 | |
| 18 Mar 2026 | ₹ -25 | -5% | ₹ 0 | ₹ 0 | |
| 17 Mar 2026 | ₹ -3 | -1% | ₹ 0 | ₹ 0 | |
| 16 Mar 2026 | ₹ 20 | 4% | ₹ 0 | ₹ 0 | |
| 13 Mar 2026 | ₹ 1 | -- | ₹ 0 | ₹ 0 | |
| 12 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 11 Mar 2026 | ₹ 66 | 12% | ₹ 0 | ₹ 0 | |
| 10 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 09 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 07 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 06 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 05 Mar 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 |
Innovision IPO Dates
| Event | Date |
|---|---|
| Open Date | 10 Mar, 2026 |
| Close Date | 17 Mar, 2026 |
| Allotment Date | 18 Mar, 2026 |
| Refund Date | 19 Mar, 2026 |
| Credit to Demat | 19 Mar, 2026 |
| Listing Date | 23 Mar, 2026 |
Innovision IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹548 |
| GMP-Based Estimate (Pre-Listing) | ₹453 (-17.3%) |
| Actual Listing Price | ₹467.70 (-14.65%) |
| Listing Gain / Loss | ₹-80.3 per share |
| Listing Date | 23 Mar, 2026 |
Is Innovision IPO GMP Reliable?
Grey market premium for Innovision IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Innovision IPO full review for a fundamentals-based assessment before making any grey market trades.
Innovision IPO IPO Kostak Rate Explained
The Kostak rate for Innovision IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Innovision IPO
The company offers a range of products and services which may include engineering solutions, system integration and customised project execution depending on client requirements. Its business model is primarily based on delivering end-to-end solutions, from design and development to implementation and maintenance. Innovision caters to both institutional and industrial clients, ensuring consistent revenue through repeat orders and long-term contracts. By focusing on operational efficiency, quality standards and scalable solutions, the company aims to achieve sustainable growth and expand its market presence.
Frequently Asked Questions about Innovision IPO
What is the GMP of Innovision IPO?
The current Grey Market Premium (GMP) of Innovision IPO is ₹ -95.
What is the Kostak Price of Innovision IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Innovision IPO is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the Subject to Sauda Price of Innovision IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What was the actual listing price of Innovision IPO?
Innovision IPO listed on March 23, 2026 at ₹467.70, against the issue price of ₹548 — a loss of -14.65%.
How did the GMP of Innovision IPO trend before listing?
The GMP of Innovision IPO was falling in its final days before listing. The GMP peaked at ₹66 on 11 March 2026. View the day-wise table above for the complete GMP history.
Explore Innovision IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!